Bentham Science Logo

Current Radiopharmaceuticals

Volume 13, 3 Issues, 2020
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Order Your Article Before Print

Track Your Manuscript:


In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Meet the Executive Guest Editor(s)

A.R. Jalilian
International Atomic Energy Agency (IAEA)
Vienna
(Austria)
Prof. Amir R. Jalilian has a PharmD. degree (1995), a PhD degree in Radiopharmacy (2000) followed by Postdoctoral fellowships from the University of Alberta, Canada and Yale School of Medicine, CT, USA. Until 2015, he was active in the development of new radiopharmaceuticals leading to the completion of clinical trials and the marketing of six radiopharmaceuticals. He has published around 300 scientific papers in peer-viewed journals and five books in various languages and supervised more than 50 MSc and PhD thesis. In 2015, he joined the Nuclear Sciences and Application Department, International Atomic Energy Agency (IAEA), Vienna Headquarters, Austria as a Radioisotope/Radiopharmaceutical Chemist. He is leading four IAEA international Collaborated Research Projects (CRP) on the topic of radioisotope and radiopharmaceutical production.


Editor-in-Chief

Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)

Biography View Full Editorial Board

Journal History

Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77

Advertisement

Webinars for Bentham AuthorsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog